Genomic classifier (ColoPrint) predicts outcome and chemotherapy benefit in stage II and III colon cancer patients

被引：0
|
作者：
Kopetz, S. [1 ]
Jiang, Z. Q. [2 ]
Overman, M. J. [1 ]
Rosenberg, R. [3 ]
Salazar, R. [4 ]
Tabernero, J. [5 ]
Stork-Sloots, L. [6 ]
Simon, I. [7 ]
Chang, G. J. [8 ]
Maru, D. M. [9 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Kantonsspital Baden, Dept Surg, Baden, Switzerland
[4] Inst Catala Oncol IDIBELL Hospitalet de Llobregat, Dept Med Oncol, Barcelona, Spain
[5] Vail dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[6] Agendia, Med Affairs, Amsterdam, Netherlands
[7] Agendia, Res & Dev, Amsterdam, Netherlands
[8] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2257
引用
收藏
页码：S514 / S515
页数：2
相关论文
共 50 条
  • [41] Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients
    Eiji Oki
    Eiji Shinto
    Mototsugu Shimokawa
    Shigeki Yamaguchi
    Megumi Ishiguro
    Seiji Hasegawa
    Yasumasa Takii
    Hideyuki Ishida
    Tetsuya Kusumoto
    Masaru Morita
    Naohiro Tomita
    Manabu Shiozawa
    Masafumi Tanaka
    Heita Ozawa
    Yojiro Hashiguchi
    Shinobu Ohnuma
    Sachiyo Tada
    Tomoko Matsushima
    Kazuo Hase
    BMC Cancer, 21
  • [42] Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy
    Custodio, Ana
    Moreno-Rubio, Juan
    Aparicio, Jorge
    Gallego-Plazas, Javier
    Yaya, Ricardo
    Maurel, Joan
    Rodriguez-Salas, Nuria
    Burgos, Emilio
    Ramos, David
    Calatrava, Ana
    Andrada, Encarna
    Diaz-Lopez, Esther
    Sanchez, Antonio
    Madero, Rosario
    Cejas, Paloma
    Feliu, Jaime
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (09) : 2226 - 2237
  • [43] Chemotherapy for Stage II Colon Cancer
    Varghese, Anna
    CLINICS IN COLON AND RECTAL SURGERY, 2015, 28 (04) : 256 - 261
  • [44] A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
    Ju, Huai-Qiang
    Zhao, Qi
    Wang, Feng
    Lan, Ping
    Wang, Zixian
    Zuo, Zhi-Xiang
    Wu, Qi-Nian
    Fan, Xin-Juan
    Mo, Hai-Yu
    Chen, Li
    Li, Ting
    Ren, Chao
    Wan, Xiang-Bo
    Chen, Gong
    Li, Yu-Hong
    Jia, Wei-Hua
    Xu, Rui-Hua
    EMBO MOLECULAR MEDICINE, 2019, 11 (10)
  • [45] A CIRCRNA SIGNATURE PREDICTS POSTOPERATIVE RECURRENCE IN STAGE II/III COLON CANCER
    Ju, Huai-Qiang
    Zhao, Qi
    Wang, Feng
    Lan, Ping
    Wang, Zixian
    Xu, Rui-Hua
    GUT, 2019, 68 : A30 - A30
  • [46] The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer
    Sada, Yvonne
    Duan, Zhigang
    El-Serag, Hashem
    Davila, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [47] LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
    Agocs, Gaelle Rhyner
    Assarzadegan, Naziheh
    Kirsch, Richard
    Dawson, Heather
    Galvan, Jose A.
    Lugli, Alessandro
    Zlobec, Inti
    Berger, Martin D.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [48] MSI plus STAGE II/III COLON CANCER PATIENTS BENEFIT FROM CAPECITABINE ADJUVANT MONOTHERAPY
    Dimovski, Aleksandar
    Matevska, Nadica
    Eftimov, Aleksandar
    Nestorovska, Aleksandra Kapedanovska
    Petrusevska, Natalija Angelovska
    Angelovska, Biljana
    Jashar, Djingis
    Mitrevski, Nikola
    Josifovski, Toni
    ANNALS OF ONCOLOGY, 2012, 23 : 106 - 106
  • [49] A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
    Mini, E.
    D'Aurizio, R.
    Perrone, G.
    Magi, A.
    Lapucci, A.
    Tassi, R.
    Napoli, C.
    Picariello, L.
    Landini, I.
    Brugia, M.
    Mazzei, T.
    Tonelli, F.
    Nobili, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Adjuvant Chemotherapy for Stage III Colon Cancer
    Taieb, Julien
    Gallois, Claire
    CANCERS, 2020, 12 (09) : 1 - 17
12345